ResearcherFirst Hospital of Jilin UniversityNo recent work listed

Baofeng Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2764-7985; OpenAlex author ID A5101430613. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2016: 2 papers

Papers 2

CCR7 regulates Twist to induce the epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma. First author DOI 10.1007/s13277-015-3819-y ↗
The adaptor protein CrkII regulates IGF-1-induced biological behaviors of pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s13277-015-3876-2 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kexin Li · 2 shared papers, 2016 · strength 0.15
- Paper CCR7 regulates Twist to induce the epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma. DOI 10.1007/s13277-015-3819-y ↗
- Paper The adaptor protein CrkII regulates IGF-1-induced biological behaviors of pancreatic ductal adenocarcinoma. DOI 10.1007/s13277-015-3876-2 ↗
Rui Liu · 1 shared paper, 2016 · strength 0.08
- Paper CCR7 regulates Twist to induce the epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma. DOI 10.1007/s13277-015-3819-y ↗
Rui Liu · 1 shared paper, 2016 · strength 0.07
- Paper The adaptor protein CrkII regulates IGF-1-induced biological behaviors of pancreatic ductal adenocarcinoma. DOI 10.1007/s13277-015-3876-2 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.